These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35840338)

  • 1. Preclinical Characterization of LY3209590, a Novel Weekly Basal Insulin Fc-Fusion Protein.
    Moyers JS; Hansen RJ; Day JW; Dickinson CD; Zhang C; Ruan X; Ding L; Brown RM; Baker HE; Beals JM
    J Pharmacol Exp Ther; 2022 Sep; 382(3):346-355. PubMed ID: 35840338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once-weekly dosing for the treatment of patients with diabetes.
    Heise T; Chien J; Beals JM; Benson C; Klein O; Moyers JS; Haupt A; Pratt EJ
    Diabetes Obes Metab; 2023 Apr; 25(4):1080-1090. PubMed ID: 36541037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo and In Vitro Characterization of Basal Insulin Peglispro: A Novel Insulin Analog.
    Owens RA; Hansen RJ; Kahl SD; Zhang C; Ruan X; Koester A; Li S; Qian HR; Farmen MW; Michael MD; Moyers JS; Cutler GB; Vick A; Beals JM
    J Pharmacol Exp Ther; 2016 Jun; 357(3):459-65. PubMed ID: 27026683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa.
    Rosenstock J; Juneja R; Beals JM; Moyers JS; Ilag L; McCrimmon RJ
    Endocr Rev; 2024 May; 45(3):379-413. PubMed ID: 38224978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing.
    Nishimura E; Pridal L; Glendorf T; Hansen BF; Hubálek F; Kjeldsen T; Kristensen NR; Lützen A; Lyby K; Madsen P; Pedersen TÅ; Ribel-Madsen R; Stidsen CE; Haahr H
    BMJ Open Diabetes Res Care; 2021 Aug; 9(1):. PubMed ID: 34413118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical pharmacology of RA15127343: In vitro and in vivo activity of a novel ultralong-acting basal insulin.
    Werner U; Bielohuby M; Korn M; Riedel J; Will M; Méndez M
    Diabetes Obes Metab; 2022 Dec; 24(12):2411-2419. PubMed ID: 35892256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
    Portha B; Serradas P
    Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
    Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Brignetti D; Luo J; Khandwala A; Reaven GM
    Diabetologia; 1999 Jan; 42(1):102-6. PubMed ID: 10027587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Is the Role of Basal Weekly Insulin in Clinical Practice? The State of the Art.
    Argano C; Priola L; Manno F; Corrao S
    Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal weekly insulins: the way of the future!
    Rosenstock J; Del Prato S
    Metabolism; 2022 Jan; 126():154924. PubMed ID: 34728221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-weekly insulins: a promising approach to reduce the treatment burden in people with diabetes.
    Trevisan R; Conti M; Ciardullo S
    Diabetologia; 2024 Aug; 67(8):1480-1492. PubMed ID: 38679644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin binding and glucose metabolism in adipocytes of streptozotocin-diabetic rats.
    Kasuga M; Akanuma Y; Iwamoto Y; Kosaka K
    Am J Physiol; 1978 Aug; 235(2):E175-82. PubMed ID: 150797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein.
    Glaesner W; Vick AM; Millican R; Ellis B; Tschang SH; Tian Y; Bokvist K; Brenner M; Koester A; Porksen N; Etgen G; Bumol T
    Diabetes Metab Res Rev; 2010 May; 26(4):287-96. PubMed ID: 20503261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in tyrosine phosphorylation of insulin receptors and a 170,000 molecular weight nonreceptor protein in vivo in skeletal muscle of streptozotocin-induced diabetic rats: effects of insulin and glucose.
    Giorgino F; Chen JH; Smith RJ
    Endocrinology; 1992 Mar; 130(3):1433-44. PubMed ID: 1531627
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Wronkowitz N; Hartmann T; Görgens SW; Dietze-Schroeder D; Indrakusuma I; Choi IY; Park SH; Lee YM; Kwon SC; Kang Y; Hompesch M; Eckel J
    Diabetes Obes Metab; 2017 Dec; 19(12):1722-1731. PubMed ID: 28497570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide-Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy.
    Sahu A; Sninsky CA; Kalra PS; Kalra SP
    Endocrinology; 1990 Jan; 126(1):192-8. PubMed ID: 2136723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adipocyte insulin binding and glucose transport in normal pregnancy and streptozotocin-induced diabetic pregnancy in the rat: evidence for a postreceptor abnormality in insulin action].
    Shimizu K; Toyoda N; Morikawa F; Sugiyama Y
    Nihon Naibunpi Gakkai Zasshi; 1983 Dec; 59(12):1894-904. PubMed ID: 6687055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term gliclazide treatment improves the in vitro glucose-induced insulin release in rats with type 2 (non-insulin-dependent) diabetes induced by neonatal streptozotocin.
    Serradas P; Bailbé D; Portha B
    Diabetologia; 1989 Aug; 32(8):577-84. PubMed ID: 2528491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moringa concanensis Nimmo ameliorates hyperglycemia in 3T3-L1 adipocytes by upregulating PPAR-γ, C/EBP-α via Akt signaling pathway and STZ-induced diabetic rats.
    Balakrishnan BB; Krishnasamy K; Choi KC
    Biomed Pharmacother; 2018 Jul; 103():719-728. PubMed ID: 29680740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.